{"id": "1399921791485706240", "created_at": "2021-06-02T02:52:19.000Z", "text": "$BTT.X BOTTOM GEM. Getting loaded. $3+ coming\ud83d\udcb8\ud83d\udcda\n\n$SPY $TSLA $SHOP  $AMZN $NVDA $ROKU $EBAY $AMD $BB $DAL $DOW $QQQ $ZNGA $AAPL $ESE $SPCE $FCEL $TRIP $BYND $MRNA $NOK $OXY $CCL $CRON $DGLY $HTZ $PENN $GMBL $CRM $GNUS $BA $WKHS $FLIR $CREX $MARK $EOLS $BLU $NOVN $ABBV $AZUL $AMC https://t.co/S51DZi2MhW", "author_id": "1392160831605854210"}
{"id": "1400045630416900098", "created_at": "2021-06-02T11:04:24.000Z", "text": "$ABBV New Long-Term Efficacy and Safety Analyses Evaluating RINVOQ\u00ae (upadacitinib) in Patients with Rheumatoid Arthritis to be Presented at EULAR 2021 Virtual Congress\nhttps://t.co/0BwlyJkkQX", "author_id": "1355194932445786112"}
{"author_id": "4436311995", "created_at": "2021-06-02T12:04:14.000Z", "id": "1400060688798830598", "text": "$ABBV - AbbVie Phase 3 Maintenance Results Show Patients with Crohn's Disease Receiving Risankizumab (SKYRIZI\u00ae) Achieved Endoscopic Response and Clinical Remission at One Year"}
